Mycoplasma genitalium, rRNA, TMA
Also known as: MGEN
Use
This assay aids in the diagnosis of Mycoplasma genitalium (Mgen) urogenital infections in both male and female patients. Mgen is a sexually transmitted pathogen linked to conditions including nongonococcal urethritis in men, cervicitis and pelvic inflammatory disease (PID) in women.3 In women, prevalence among cervicitis cases ranges from approximately 10%–30% and up to 22% of PID cases, while in men it is implicated in 15%–25% of nongonococcal urethritis. NAATs including this rRNA-based test are preferred methods due to the organism’s difficulty to culture and detect via microscopy.4,5
Special Instructions
Not provided.
Limitations
Not provided.
New York Approved
Methodology
Other
Biomarkers
Result Turnaround Time
1-4 days
Related Documents
For more information, please review the documents below
Specimen
Vaginal Swab
Volume
Not provided
Minimum Volume
Not provided
Container
Aptima Multitest Swab Specimen Collection Kit
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 60 days |
| Refrigerated | 60 days |
| Frozen | 90 days |
Other tests from different labs that may be relevant